1. Efficacy and safety of gemigliptin, a dipeptidyl peptidase‐4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24‐week, multicentre, randomized, double‐blind, placebo‐controlled study (TROICA study). Issue 5 (17th February 2017) Authors: Ahn, Chang Ho; Han, Kyung Ah; Yu, Jae Myung; Nam, Joo Young; Ahn, Kyu Jeung; Oh, Tae Keun; Lee, Hyoung Woo; Lee, Dae Ho; Kim, Jaetaek; Chung, Choon Hee; Park, Tae Sun; Kim, Byung Joon; Park, Seok Won; Park, Hyeong Kyu; Lee, Kwang Jae; Kim, Sang‐Wook; Park, Jeong Hyun; Ko, Kwan Pyo; Kim, Chong Hwa... Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 5(2017) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗